117 related articles for article (PubMed ID: 7888419)
1. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts.
Montgomery DB; Roberts A; Green M; Bullock T; Baldwin D; Montgomery SA
Eur Arch Psychiatry Clin Neurosci; 1994; 244(4):211-5. PubMed ID: 7888419
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine treatment in patients with recurrent brief depression.
Stamenkovic M; Blasbichier T; Riederer F; Pezawas L; Brandstätter N; Aschauer HN; Kasper S
Int Clin Psychopharmacol; 2001 Jul; 16(4):221-6. PubMed ID: 11459336
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine in the prevention of depressive recurrences: a double-blind study.
Gilaberte I; Montejo AL; de la Gandara J; Perez-Sola V; Bernardo M; Massana J; Martin-Santos R; Santiso A; Noguera R; Casais L; Perez-Camo V; Arias M; Judge R;
J Clin Psychopharmacol; 2001 Aug; 21(4):417-24. PubMed ID: 11476126
[TBL] [Abstract][Full Text] [Related]
4. A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
Heiligenstein JH; Tollefson GD; Faries DE
Int Clin Psychopharmacol; 1993; 8(4):247-51. PubMed ID: 8277143
[TBL] [Abstract][Full Text] [Related]
5. Treating the substance-abusing suicidal patient.
Cornelius JR; Salloum IM; Lynch K; Clark DB; Mann JJ
Ann N Y Acad Sci; 2001 Apr; 932():78-90; discussion 91-3. PubMed ID: 11411192
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.
Leon AC; Keller MB; Warshaw MG; Mueller TI; Solomon DA; Coryell W; Endicott J
Am J Psychiatry; 1999 Feb; 156(2):195-201. PubMed ID: 9989554
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal view of triggers and thresholds of suicidal behavior in depression.
Pezawas L; Stamenkovic M; Jagsch R; Ackerl S; Putz C; Stelzer B; Moffat RR; Schindler S; Aschauer H; Kasper S
J Clin Psychiatry; 2002 Oct; 63(10):866-73. PubMed ID: 12416595
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
Tollefson GD; Fawcett J; Winokur G; Beasley CM; Potvin JH; Faries DE; Rampey AH; Sayler ME
Ann Clin Psychiatry; 1993 Dec; 5(4):209-24. PubMed ID: 8312978
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
[TBL] [Abstract][Full Text] [Related]
10. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders.
Warshaw MG; Keller MB
J Clin Psychiatry; 1996 Apr; 57(4):158-66. PubMed ID: 8601551
[TBL] [Abstract][Full Text] [Related]
11. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
[TBL] [Abstract][Full Text] [Related]
12. The duration, nature and recurrence rate of brief depressions.
Montgomery SA; Montgomery D; Baldwin D; Green M
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):729-35. PubMed ID: 2293253
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
Amsterdam JD; Shults J
Int Clin Psychopharmacol; 2005 Sep; 20(5):257-64. PubMed ID: 16096516
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
Detke HC; DelBello MP; Landry J; Usher RW
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
[TBL] [Abstract][Full Text] [Related]
16. How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo.
Tollefson GD; Holman SL
Int Clin Psychopharmacol; 1994; 9(4):245-50. PubMed ID: 7868846
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine trial in suicidal depressed alcoholics.
Cornelius JR; Salloum IM; Cornelius MD; Perel JM; Thase ME; Ehler JG; Mann JJ
Psychopharmacol Bull; 1993; 29(2):195-9. PubMed ID: 8290665
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
[TBL] [Abstract][Full Text] [Related]
19. Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
Heiligenstein JH; Tollefson GD; Faries DE
J Affect Disord; 1994 Mar; 30(3):163-73. PubMed ID: 8006243
[TBL] [Abstract][Full Text] [Related]
20. A preliminary trial of fluoxetine in refractory borderline patients.
Cornelius JR; Soloff PH; Perel JM; Ulrich RF
J Clin Psychopharmacol; 1991 Apr; 11(2):116-20. PubMed ID: 2056138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
